Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17661426rdf:typepubmed:Citationlld:pubmed
pubmed-article:17661426lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:17661426lifeskim:mentionsumls-concept:C0013303lld:lifeskim
pubmed-article:17661426lifeskim:mentionsumls-concept:C0023570lld:lifeskim
pubmed-article:17661426lifeskim:mentionsumls-concept:C0085415lld:lifeskim
pubmed-article:17661426lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:17661426lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17661426pubmed:issue8lld:pubmed
pubmed-article:17661426pubmed:dateCreated2007-7-30lld:pubmed
pubmed-article:17661426pubmed:abstractTextWe assessed prospectively clinical and quality of life changes in 9 patients with Parkinson's disease (PD; H&Y > or = 3) with severe motor fluctuations and dyskinesia who started continuous daily levodopa duodenal infusion through percutaneous endoscopic gastrostomy. Seven patients completed the follow-up period. Duration of "off" periods and time with disabling dyskinesia shortened significantly in all patients (P < 0.01). Total daily dose of levodopa infused did not differ from baseline equivalents. There were significant improvements in UPDRS-II (activities of daily living) and -IV (motor complications) in the "on" condition (P < 0.02), and in four PDQ-39 domains (mobility, activities of daily living, stigma, bodily discomfort; P < 0.05). Two patients withdrew for adverse events. Our results demonstrate that a satisfactory therapeutic window can be achieved and maintained for several months in advanced PD patients.lld:pubmed
pubmed-article:17661426pubmed:languageenglld:pubmed
pubmed-article:17661426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17661426pubmed:citationSubsetIMlld:pubmed
pubmed-article:17661426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17661426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17661426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17661426pubmed:statusMEDLINElld:pubmed
pubmed-article:17661426pubmed:monthJunlld:pubmed
pubmed-article:17661426pubmed:issn0885-3185lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:ManciniFrance...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:AntoniniAngel...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:CanesiMargher...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:PezzoliGianni...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:LopianoLeonar...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:ManfrediLuigi...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:ZibettiMauriz...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:IsaiasIoannis...lld:pubmed
pubmed-article:17661426pubmed:authorpubmed-author:Dal...lld:pubmed
pubmed-article:17661426pubmed:issnTypePrintlld:pubmed
pubmed-article:17661426pubmed:day15lld:pubmed
pubmed-article:17661426pubmed:volume22lld:pubmed
pubmed-article:17661426pubmed:ownerNLMlld:pubmed
pubmed-article:17661426pubmed:authorsCompleteYlld:pubmed
pubmed-article:17661426pubmed:pagination1145-9lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:meshHeadingpubmed-meshheading:17661426...lld:pubmed
pubmed-article:17661426pubmed:year2007lld:pubmed
pubmed-article:17661426pubmed:articleTitleDuodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.lld:pubmed
pubmed-article:17661426pubmed:affiliationParkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy. angelo3000@yahoo.comlld:pubmed
pubmed-article:17661426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17661426pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17661426lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17661426lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17661426lld:pubmed